Urology Annals
About UA | Search | Ahead of print | Current Issue | Archives | Instructions | Online submissionLogin 
Urology Annals
  Editorial Board | Subscribe | Advertise | Contact
Users Online: 275   Home Print this page  Email this page Small font size Default font size Increase font size


 
Table of Contents
COMMENTARY
Year : 2018  |  Volume : 10  |  Issue : 4  |  Page : 420  

Fosfomycin for management of persistent female lower urinary tract infection


1 Sanitation 1 Medical Academic Center, Bangkok, Thailand
2 Tropical Medicine, Hainan Medical University, China

Date of Web Publication12-Oct-2018

Correspondence Address:
Dr. Beuy Joob
Sanitation 1 Medical Academic Center, Bangkok
Thailand
Login to access the Email id


DOI: 10.4103/0974-7796.243209

PMID: 30386099

Rights and Permissions

How to cite this article:
Joob B, Wiwanitkit V. Fosfomycin for management of persistent female lower urinary tract infection. Urol Ann 2018;10:420

How to cite this URL:
Joob B, Wiwanitkit V. Fosfomycin for management of persistent female lower urinary tract infection. Urol Ann [serial online] 2018 [cited 2018 Dec 12];10:420. Available from: http://www.urologyannals.com/text.asp?2018/10/4/420/243209

We would like to make a commentary and share experience on the previous issue raised by Sultan et al.[1] Sultan et al. performed in vitro study and concluded that “Fosfomycin has emerged as a promising option, especially in cases involving multi-drug-resistant pathogens in which previous antibiotics have failed to cure the infection.”[1] In fact, it is no doubt that persistent female lower urinary tract infection is a very important problem in urology and this is considered a “major socioeconomic problem.”[2] Here, the authors have a case of an elderly Thai female who get many antibiotics (penicillin, co-trimoxazole and levofloxacin) for treatment of chronic osteomyelitis for about 2 years and she also has persistent lower urinary tract infection with several acute attack episodes. This patient also has underlying poorly controlled diabetes mellitus. Within the past 1 year, she got 6 acute attacks, and the use of standard intravenous cephalosphorin treatment could not clear the bacteriuria. The urine culture showed the extended-spectrum β-lactamase-producing  Escherichia More Details coli (FOREST). The case was referred to the infectious medicine specialist, and the patient was finally prescribed for single dose fosfomycin therapy. Of interest, clearance of the persistent bacteriuria could be seen within 1 week. The negative urine culture was also detected. This case can confirm the dramatic therapeutic effect of oral fosfomycin for persistent female lower urinary tract infection. Of interest, this is the first report on the patient from Southeast Asia region, which is presently lack for the data on the clinical effectiveness of fosfomycin.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest



 
   References Top

1.
Sultan A, Rizvi M, Khan F, Sami H, Shukla I, Khan HM. Increasing antimicrobial resistance among uropathogens: Is fosfomycin the answer? Urol Ann 2015;7:26-30.  Back to cited text no. 1
[PUBMED]  [Full text]  
2.
Ibishev KH. Some aspects of the treatment of persistent lower urinary tract infections in women. Urologiia 2014;5:30-2, 34.  Back to cited text no. 2
    




 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    References

 Article Access Statistics
    Viewed189    
    Printed0    
    Emailed0    
    PDF Downloaded51    
    Comments [Add]    

Recommend this journal